Arcturus Therapeutics: Q3 Earnings Insights

Arcturus Therapeutics ARCT reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Arcturus Therapeutics beat estimated earnings by 63.91%, reporting an EPS of $-0.61 versus an estimate of $-1.69.

Revenue was up $31.77 million from the same period last year.

Last quarter the company missed on EPS by $1.77 which was followed by a 19.22% drop in the share price the next day.

Here's a look at Arcturus Therapeutics's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-0.21	0.06	0.98	-1.81
EPS Actual	-1.98	0.62	4.33	-1.33
Revenue Estimate	48.50M	37.94M	72.68M	3.42M
Revenue Actual	10.52M	80.28M	160.29M	13.37M

To track all earnings releases for Arcturus Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar